ORCS
ActiveSummary
ORCS has been active since 2002 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €366k and a net result of €17k. Equity is growing by ~55.7% per year across the filed fiscal years. Its solvency ranks better than 44% of 16618 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2025
Axes · tick = 2024
Profitability72▼-12
Solvency81▼-10
Growth52▼-26
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €30k at 30 days acceptable
Liquidity ample (current ratio 3.38 against 3.96 in 2024; short-term debt: 11.1% and cash: 34.6% of total assets), and 44.2% of the assets are financed with debt.
Credit check for your own amount and term
Open the credit simulator : see how the verdict changes with amount, term and advance.
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
55.8%
Return on assets
2.7%
Age of the figures
15 mo
neutral · Latest accounts filed on time
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 28-01-2026, 3 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
3 d early
2024
74 d early
2023
1 d early
2022
on the day
2021
18 d early
2020
6 d early
2019
17 d early
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 30-06-2026 and is due by 31-01-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
30-06-2026 close25-09-2026 today31-01-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€366k▲ 5.0%
2024 · €348k
Total assets
€656k▲ 23.9%
2024 · €529k
Net result
€17k▼ 72.6%
2024 · €64k
Working capital
€173k▼ 35.4%
2024 · €268k
Trend over the years
Click a name to add, emphasise or remove a line.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Operating result€153k▲ 95.2%€108k▼ 29.5%€288k▲ 167%€96k▼ 66.7%€29k▼ 69.5%
Net result€101k▲ 89.7%€58k▼ 43.0%€214k▲ 270%€64k▼ 70.2%€17k▼ 72.6%
Equity€-21k▲ 83.0%€71k€285k▲ 300%€348k▲ 22.3%€366k▲ 5.0%
Total assets€426k▼ 6.0%€348k▼ 18.3%€488k▲ 40.3%€529k▲ 8.5%€656k▲ 23.9%
Debt€447k▼ 22.4%€277k▼ 38.1%€203k▼ 26.6%€181k▼ 10.8%€290k▲ 60.4%
Working capital€-99k▲ 44.1%€24k€171k▲ 622%€268k▲ 57.3%€173k▼ 35.4%
Staff (FTE)3.1▲ 55.0%3▼ 3.2%3=5.1▲ 70.0%5.7▲ 11.8%
Turnover and EBIT margin not published: the abbreviated or micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result has fallen two years in a row; 2025 is 70% below 2024 and is the lowest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €656k
Fixed assets
€410k ▲ 141%
Current assets
€246k ▼ 31.5%
Equity and liabilities €656k
Equity
€366k ▲ 5.0%
Debt
€290k ▲ 60.4%
Debt's share of the balance-sheet total rises from 34.2% to 44.2%. Equity and debt are higher.
Key figures and ratios
EBITDA
€101k▼
2024 · €166k
Cash flow
€89k▼
2024 · €133k
Current ratio
3.38▼
2024 · 3.96
Debt to equity
0.79▲
2024 · 0.52
ROE
4.8%▼
2024 · 18.2%
ROA
2.7%▼
2024 · 12.0%
Interest coverage
27.43▼
2024 · 50.43
Debt ≤ 1 year
€73k▼
2024 · €91k
Debt > 1 year
€130k▲
2024 · €17k
Income taxes
€6k▼
2024 · €39k
Staff costs
€267k▲
2024 · €208k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Remuneration, social security and pensions62 | - | €171k | €182k | €208k | €267k | ▲ 28.5% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €76k | €66k | €64k | €70k | €72k | ▲ 3.4% |
| Other operating charges640/8 | - | €3k | €2k | €3k | €3k | ▲ 0.9% |
| Gross operating margin9900 | €397k | €348k | €536k | €376k | €371k | ▼ 1.4% |
| Operating profit (loss)9901 | €153k | €108k | €288k | €96k | €29k | ▼ 69.5% |
| Financial income75/76B | - | €1 | €5k | €9k | - | - |
| Recurring financial income75 | - | €1 | €5k | €9k | - | - |
| Financial charges65/66B | - | €9k | €4k | €3k | €6k | ▲ 82.0% |
| Recurring financial charges65 | €12k | €9k | €4k | €3k | €4k | ▲ 12.3% |
| Non-recurring financial charges66B | - | - | - | - | €2k | - |
| Profit (loss) for the period before taxes9903 | €141k | €99k | €289k | €102k | €23k | ▼ 77.2% |
| Income taxes67/77 | €40k | €41k | €75k | €39k | €6k | ▼ 84.8% |
| Profit (loss) for the period9904 | €101k | €58k | €214k | €64k | €17k | ▼ 72.6% |
| Profit (loss) for the period to be appropriated9905 | €101k | €58k | €214k | €64k | €17k | ▼ 72.6% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €426k | €348k | €488k | €529k | €656k | ▲ 23.9% |
| Fixed assets21/28 | €268k | €203k | €217k | €170k | €410k | ▲ 141% |
| Intangible fixed assets21 | - | - | - | - | €0 | - |
| Tangible fixed assets22/27 | €266k | €202k | €216k | €165k | €410k | ▲ 148% |
| Land and buildings22 | - | €150k | €113k | €77k | - | - |
| Plant, machinery and equipment23 | - | €39k | €94k | €84k | €161k | ▲ 93.0% |
| Furniture and vehicles24 | - | €13k | €9k | €5k | €19k | ▲ 299% |
| Other tangible fixed assets26 | - | - | - | - | €230k | - |
| Financial fixed assets28 | €1k | €1k | €1k | €5k | €250 | ▼ 95.1% |
| Current assets29/58 | €158k | €145k | €270k | €359k | €246k | ▼ 31.5% |
| Amounts receivable within one year40/41 | €62k | €78k | €202k | €243k | €10k | ▼ 95.7% |
| Trade receivables40 | - | €1k | - | - | - | - |
| Other amounts receivable41 | - | €77k | €202k | €243k | €10k | ▼ 95.7% |
| Cash at bank and in hand54/58 | €96k | €66k | €63k | €85k | €227k | ▲ 168% |
| Deferred charges and accrued income490/1 | - | €460 | €5k | €32k | €8k | ▼ 73.6% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €426k | €348k | €488k | €529k | €656k | ▲ 23.9% |
| Equity10/15 | €-21k | €71k | €285k | €348k | €366k | ▲ 5.0% |
| Contributions10/11 | - | €12k | €12k | €12k | €12k | = |
| Reserves13 | €2k | €2k | €272k | €336k | €353k | ▲ 5.2% |
| Distributable reserves133 | - | €2k | €272k | €336k | €353k | ▲ 5.2% |
| Profit (loss) carried forward14 | €-35k | €57k | - | - | - | - |
| Amounts payable17/49 | €447k | €277k | €203k | €181k | €290k | ▲ 60.4% |
| Amounts payable after more than one year17 | €106k | €74k | €46k | €17k | €130k | ▲ 666% |
| Financial debts170/4 | - | €74k | €46k | €17k | €130k | ▲ 666% |
| Amounts payable within one year42/48 | €257k | €121k | €100k | €91k | €73k | ▼ 19.8% |
| Current portion of amounts payable after more than one year42 | - | €38k | €38k | €38k | €26k | ▼ 31.2% |
| Financial debts43 | - | €4k | - | - | - | - |
| Credit institutions430/8 | - | €4k | - | - | - | - |
| Trade debts44 | €4k | €1k | €7k | €26k | €6k | ▼ 78.8% |
| Suppliers440/4 | - | €1k | €7k | €26k | €6k | ▼ 78.8% |
| Taxes, remuneration and social security45 | - | €5k | €55k | €27k | €31k | ▲ 15.4% |
| Taxes450/3 | - | €5k | €47k | €11k | €555 | ▼ 94.8% |
| Remuneration and social security454/9 | - | - | €8k | €16k | €30k | ▲ 88.0% |
| Other amounts payable47/48 | - | €73k | - | - | €10k | - |
| Accrued charges and deferred income492/3 | - | €81k | €57k | €73k | €87k | ▲ 19.1% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €101k | €58k | €214k | €64k | €17k | ▼ 72.6% |
| + Depreciation and write-downs630 | €76k | €66k | €64k | €70k | €72k | ▲ 3.4% |
| Operating cash flow (approximation) | €177k | €124k | €277k | €133k | €89k | ▼ 32.9% |
| Investment in fixed assets (approximation) | - | €-1k | €-78k | €-22k | €-312k | ▼ 1,290% |
| Change in cash | - | €-30k | €-3k | €22k | €143k | ▲ 558% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
28-01
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
30-06
Financial
Weakest financial yearnet €17k ▼72.6%
Net result drops to €17k, the lowest in the series.
2024
18-11
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema
30-01
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
30-06
Financial
Highest result since 2019net €214k ▲270%
Operating result €288k, net result €214k, both a record.
30-06
Financial
Liquidity doublescurrent ratio 2.71
Current ratio from 1.20 to 2.71; short-term debt falls from €121k to €100k.
30-06
Financial
Equity above €200kEq €285k ▲300%
5 profitable years in a row build equity to €285k.
31-01
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
13-01
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
25-01
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema
2020
14-01
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema
2019
14-01
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema
2018
15-01
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema
2017
13-01
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 6 acts read
About the unread acts
We know of 6 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
6 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Schilde · 1 establishment unit since 2001
Ground area
910 m²
Building footprint
463 m²
Volume, LiDAR
3,805 m³
Parcel 11922B0536/00A004, Flanders · tallest building 14.4 m, ±3 floors. Linked by address, not a title deed.
3
companies at this address
See who is registered here
1 establishment unit
Turnhoutsebaan 364, 2970 Schilde
since 20012.228.563.023
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 11922B0536/00A004 | Flanders | 910 m² | 1 · 463 m² | 14.3 m · 3 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Public money · subsidies and aid
Flemish government
2023 to 2025 · 2 entries · 3,191 EUR awarded · 3,095 EUR paid| Year | Entries | awarded | paid |
|---|---|---|---|
| 2025 | 1 | 1,091 EUR | 995 EUR |
| 2023 | 1 | 2,100 EUR | 2,100 EUR |
Schemes
Subsidie voor opleiding en advies voor kmo's en zelfstandigen (kmo-portefeuille)
Similar companies · same sector, comparable size
DOCTEUR ANTOINE VANDERPERREN
BE 0793.673.695
Nandrin · Eq €365,774
Dr. Brack
BE 0842.111.636
Lievegem · Eq €365,782
Dr. Anneleen D’haene - Psychiater
BE 0797.810.152
Keerbergen · Eq €365,916
Dr. Leen Clijsters
BE 0751.888.966
Bree · Eq €365,920
Debakker Andrée
BE 0447.090.420
Zonnebeke · Eq €366,074
Of 16,630 companies in sector 86220 we hold annual accounts for 7,979. 6,615 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded14-01-2002
Fiscal year end30-06
Activities, NACEBEL 2025
86220Specialist medical practice
Scores and ratios are computed by Checked and are not a credit decision.